DKS CO. LTD. · 第一工業製薬株式会社
Ownership & governance
Executives 5Directors 10Avg age 68Avg tenure 6.4y
TS
Takashi Sakamoto
Chairman
Age 78Since 2013-05-31
+14
Executives5
NY
Naoki Yamaji
President
Age 62Since 2022-03-31
HM
Hisato Morishima
Chief Administrative Officer
—Since 2022-03-31
YI
Yoko Ito
Investor Relations Contact
——
YH
Yoshiyuki Hashimoto
Comptroller/Controller/Auditor
—Since 2025-06-24
NS
Naofumi Sainai
General Counsel
—Since 2022-03-31
Board of directors10
TS
Takashi Sakamoto
Chairman
Age 78Since 2013-05-31
SA
Sunao Aoki
Director/Board Member
Age 78Since 2014-05-31
IK
Ichinari Kawamura
Director/Board Member
Age 64Since 2018-05-31
OO
Osami Okamoto
Director/Board Member
Age 61Since 2017-05-31
NY
Naoki Yamaji
Director/Board Member
Age 62Since 2017-05-31
TT
Tsutomu Taniguchi
Director/Board Member
Age 73Since 2017-05-31
MS
Mami Sakamoto
Director/Board Member
—Since 2025-06-24
KO
Kikuo Okuyama
Director/Board Member
—Since 2021-06-24
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Nomura Asset Management Co., Ltd. | 7.098 % | 758,400 |
| Akira Katayama | 4.895 % | 523,000 |
| DAIICHI LIFE GROUP, INC. | 4.296 % | 459,000 |
| Sumitomo Mitsui DS Asset Management Co., Ltd. | 4.182 % | 446,800 |
| Dai Ichi Kogyo Seiyaku Business Association | 3.51 % | 375,000 |
Catalog · 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus none
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.